The present invention provides methods for facilitating metabolic control
in a subject by decreasing the level of Il-1.beta. in the GCF. The
present invention further provides methods for decreasing the level of
circulating TNF in a subject. Also provided are uses of anti-inflammatory
agents in these methods.